Article info
Image of the moment
Paraneoplastic opsoclonus-myoclonus-ataxia syndrome secondary to ovarian cancer
- Correspondence to Dr Andrew W McHattie, Neurology, St George's Hospital Atkinson Morley Regional Neuroscience Centre, London SW17 0QT, UK; AndrewWilliam.mchattie{at}nhs.net
Citation
Paraneoplastic opsoclonus-myoclonus-ataxia syndrome secondary to ovarian cancer
Publication history
- Accepted April 7, 2021
- First published May 13, 2021.
Online issue publication
September 17, 2021
Article Versions
- Previous version (13 May 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Eye movements in amyotrophic lateral sclerosis and its mimics: a review with illustrative cases
- Diplopia and eye movement disorders
- Supranuclear gaze palsy and opsoclonus after Diazinon poisoning
- Vestibular reflexes and positional manoeuvres
- Drug treatments for eye movement disorders
- Sequential fluctuating paraneoplastic ocular flutter–opsoclonus–myoclonus syndrome and Lambert–Eaton myasthenic syndrome in small-cell lung cancer
- Ocular contrapulsion in multiple sclerosis: clinical features and pathophysiological mechanisms
- Whipple’s disease mimicking progressive supranuclear palsy: the diagnostic value of eye movement recording
- A case report on fixation instability in Parkinson’s disease with bilateral deep brain stimulation implants
- Abnormalities of optokinetic nystagmus in progressive supranuclear palsy